Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity.
作者信息
Muller G W, Corral L G, Shire M G, Wang H, Moreira A, Kaplan G, Stirling D I
机构信息
Celgene Corporation, Warren, New Jersey 07059, USA.
出版信息
J Med Chem. 1996 Aug 16;39(17):3238-40. doi: 10.1021/jm9603328.
PMID:8765505
Abstract
摘要
Zotero 插件